Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Alper M, van Sijl"'
Autor:
Rabia, Agca, Alper M, van Sijl, Saskia, Vosslamber, Alexandre E, Voskuyl, Cor L, Verweij, Michael T, Nurmohamed
Publikováno v:
Agca, R, van Sijl, A M, Vosslamber, S, Voskuyl, A E, Verweij, C L & Nurmohamed, M T 2022, ' Interferon regulatory factor 5 gene variants rs2004640 and rs4728142 are associated with carotid intima media thickness but not with cardiovascular events in rheumatoid arthritis ', Clinical and Experimental Rheumatology, vol. 40, no. 1, pp. 64-68 . https://doi.org/10.55563/clinexprheumatol/pf511x
Clinical and Experimental Rheumatology, 40(1), 64-68. Clinical and Experimental Rheumatology S.A.S.
Clinical and Experimental Rheumatology, 40(1), 64-68. Clinical and Experimental Rheumatology S.A.S.
OBJECTIVES: Rheumatoid arthritis (RA) is associated with cardiovascular (CV) morbidity and mortality. Interferon regulatory factor 5 (IRF5) gene polymorphisms rs2004640 and rs4728142 have been associated with autoimmune diseases, but also with athero
Autor:
Annelies B. Blanken, Reinder Raadsen, Rabia Agca, Alper M. van Sijl, Yvo M. Smulders, Michael T. Nurmohamed
Publikováno v:
Blanken, A B, Raadsen, R, Agca, R, van Sijl, A M, Smulders, Y M & Nurmohamed, M T 2022, ' Effect of anti-inflammatory therapy on vascular biomarkers for subclinical cardiovascular disease in rheumatoid arthritis patients ', Rheumatology International . https://doi.org/10.1007/s00296-022-05226-w
Rheumatology International. Springer Verlag
Rheumatology International. Springer Verlag
Objective To assess the effect of 4 years of anti-inflammatory therapy on markers of subclinical vascular disease in rheumatoid arthritis patients. Methods Carotid intima media thickness (IMT), augmentation index (AIx@75) and pulse wave velocity (PWV
Autor:
Alexandre E. Voskuyl, Conny J. van der Laken, Michael T. Nurmohamed, Ronald Boellaard, Yvo M. Smulders, Alper M. van Sijl, Rabia Agca, Annelies B. Blanken
Publikováno v:
Rheumatology (Oxford, England)
Agca, R, Blanken, A B, van Sijl, A M, Smulders, Y M, Voskuyl, A E, van der Laken, C, Boellaard, R & Nurmohamed, M T 2021, ' Arterial wall inflammation is increased in rheumatoid arthritis compared with osteoarthritis, as a marker of early atherosclerosis ', Rheumatology (United Kingdom), vol. 60, no. 7, pp. 3360-3368 . https://doi.org/10.1093/rheumatology/keaa789
Rheumatology (United Kingdom), 60(7), 3360-3368. Oxford University Press
Agca, R, Blanken, A B, van Sijl, A M, Smulders, Y M, Voskuyl, A E, van der Laken, C, Boellaard, R & Nurmohamed, M T 2021, ' Arterial wall inflammation is increased in rheumatoid arthritis compared with osteoarthritis, as a marker of early atherosclerosis ', Rheumatology (United Kingdom), vol. 60, no. 7, pp. 3360-3368 . https://doi.org/10.1093/rheumatology/keaa789
Rheumatology (United Kingdom), 60(7), 3360-3368. Oxford University Press
Objective RA is associated with higher risk of cardiovascular (CV) disease. Ongoing systemic inflammation is presumed to accelerate atherosclerosis by increasing inflammation in the arterial wall. However, evidence supporting this hypothesis is limit
Autor:
Karel-Jan D F Lensen, Alper M van Sijl, Alexandre E Voskuyl, Conny J van der Laken, Martijn W Heymans, Emile F I Comans, Mike T Nurmohamed, Yvo M Smulders, Ronald Boellaard
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0181847 (2017)
18F-FDG-PET(/CT) is increasingly used in studies aiming at quantifying atherosclerotic plaque inflammation. Considerable methodological variability exists. The effect of data acquisition and image analysis parameters on quantitative uptake measures,
Externí odkaz:
https://doaj.org/article/8c7ad08000c04cc7b34542a77a375bce
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e87965 (2014)
OBJECTIVE: To evaluate the risk of cardiovascular disease in patients with rheumatoid arthritis exposed to glucocorticoids. METHODS: Retrospective analysis of exposure to glucocorticoids in a prospective cohort of 353 patients with rheumatoid arthrit
Externí odkaz:
https://doaj.org/article/c7ca35d0b9b44d819c6d18aac183fa29
Autor:
Calin D. Popa, Dirkjan van Schaardenburg, Ed N. Griep, Mirian Starmans-Kool, D. Marsman, Laurette van Boheemen, Michael T. Nurmohamed, Wouter H Bos, Alper M. van Sijl, Marian H. van Beers-Tas, Samina A. Turk, Maarten Boers
Publikováno v:
RMD Open, 7(1):e001591. BMJ Publishing Group
RMD open, 7(1):e001591. BMJ Publishing Group
RMD Open, Vol 7, Iss 1 (2021)
RMD Open
van Boheemen, L, Turk, S, Beers-Tas, M V, Bos, W, Marsman, D, Griep, E N, Starmans-Kool, M, Popa, C D, van Sijl, A, Boers, M, Nurmohamed, M T & van Schaardenburg, D 2021, ' Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: Results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial ', RMD Open, vol. 7, no. 1, e001591 . https://doi.org/10.1136/rmdopen-2021-001591
RMD open, 7(1):e001591. BMJ Publishing Group
RMD Open, Vol 7, Iss 1 (2021)
RMD Open
van Boheemen, L, Turk, S, Beers-Tas, M V, Bos, W, Marsman, D, Griep, E N, Starmans-Kool, M, Popa, C D, van Sijl, A, Boers, M, Nurmohamed, M T & van Schaardenburg, D 2021, ' Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: Results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial ', RMD Open, vol. 7, no. 1, e001591 . https://doi.org/10.1136/rmdopen-2021-001591
ObjectivesPersons at high risk of rheumatoid arthritis (RA) might benefit from a low-risk pharmacological intervention aimed at primary prevention. Previous studies demonstrated disease-modifying effects of statins in patients with RA as well as an a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a52ebb5bb7e0e3ad5eef3550b93c042
https://research.vumc.nl/en/publications/216fdbf1-4b47-49aa-9b2f-da296778c04b
https://research.vumc.nl/en/publications/216fdbf1-4b47-49aa-9b2f-da296778c04b
Autor:
Conny J. van der Laken, Alper M. van Sijl, Alexandre E. Voskuyl, Annelies B. Blanken, Yvo M. Smulders, Ronald Boellaard, Rabia Agca, Michael T. Nurmohamed
Publikováno v:
Blanken, A B, Agca, R, van Sijl, A M, Voskuyl, A E, Boellaard, R, Smulders, Y M, van der Laken, C J & Nurmohamed, M T 2021, ' Arterial wall inflammation in rheumatoid arthritis is reduced by anti-inflammatory treatment ', Seminars in Arthritis and Rheumatism, vol. 51, no. 2, pp. 457-463 . https://doi.org/10.1016/j.semarthrit.2021.03.008
Seminars in Arthritis and Rheumatism, 51(2), 457-463. W.B. Saunders Ltd
Seminars in Arthritis and Rheumatism, 51(2), 457-463. W.B. Saunders Ltd
Background Rheumatoid arthritis (RA) patients have an increased risk of cardiovascular disease (CVD), partly due to an increased prevalence of cardiovascular risk factors, but also due to chronic systemic inflammation inducing atherosclerotic changes
Autor:
Conny J. van der Laken, Emile F.I. Comans, Alper M. van Sijl, Karel-Jan D. F. Lensen, Michael T. Nurmohamed, Martijn W. Heymans, Yvo M. Smulders, Ronald Boellaard, Alexandre E. Voskuyl
Publikováno v:
Lensen, K-J D F, van Sijl, A M, Voskuyl, A E, van der Laken, C J, Heymans, M W, Comans, E F I, Nurmohamed, M T, Smulders, Y M & Boellaard, R 2017, ' Variability in quantitative analysis of atherosclerotic plaque inflammation using 18F-FDG PET/CT ', PLoS ONE, vol. 12, no. 8, pp. e0181847 . https://doi.org/10.1371/journal.pone.0181847
PLoS ONE, 12(8). Public Library of Science
PLoS ONE, Vol 12, Iss 8, p e0181847 (2017)
PLoS ONE
PLoS ONE, 12(8). Public Library of Science
PLoS ONE, Vol 12, Iss 8, p e0181847 (2017)
PLoS ONE
BACKGROUND: 18F-FDG-PET(/CT) is increasingly used in studies aiming at quantifying atherosclerotic plaque inflammation. Considerable methodological variability exists. The effect of data acquisition and image analysis parameters on quantitative uptak
Autor:
Yvo M. Smulders, Mike J L Peters, Erik H. Serné, Alper M. van Sijl, Irene E. van der Horst-Bruinsma, Michael T. Nurmohamed, Izhar C. van Eijk
Publikováno v:
van Sijl, A M, van Eijk, I C, Peters, M J L, Serne, E H, van der Horst-Bruinsma, I E, Smulders, Y M & Nurmohamed, M T 2015, ' Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitis ', Annals of the Rheumatic Diseases, vol. 74, no. 1, pp. 119-123 . https://doi.org/10.1136/annrheumdis-2013-203934
Annals of the Rheumatic Diseases, 74(1), 119-123. BMJ Publishing Group
Annals of the Rheumatic Diseases, 74(1), 119-123. BMJ Publishing Group
BackgroundAnkylosing spondylitis (AS) is associated with an increased cardiovascular risk that might be due to the chronic underlying inflammatory process. We investigated whether subclinical atherosclerosis of the carotid artery in patients with AS
Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion
Publikováno v:
Therapeutic Advances in Cardiovascular Disease, 5(4), 166-181. SAGE Publications Ltd
van den Oever, I A, van Sijl, A M & Nurmohamed, M T 2013, ' Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion. ', Therapeutic Advances in Cardiovascular Disease, vol. 5, no. 4, pp. 166-181 . https://doi.org/10.1177/1759720x13491025
van den Oever, I A, van Sijl, A M & Nurmohamed, M T 2013, ' Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion. ', Therapeutic Advances in Cardiovascular Disease, vol. 5, no. 4, pp. 166-181 . https://doi.org/10.1177/1759720x13491025
The risk of cardiovascular morbidity and mortality is increased in rheumatoid arthritis. The classical cardiovascular risk factors, including smoking, hypertension, dyslipidaemia, insulin resistance and diabetes mellitus, obesity and physical inactiv